Adipogen/Poly-SUMO2 Wild-type Chains (2-8) (human) (rec.)/AG-40T-0321-C025/25 ?g
重組蛋白
商品編號
AG-40T-0321-C025
品牌
Adipogen
公司
Adipogen
公司分類(lèi)
Proteins
Size
25 ?g
商品信息
More Information
Product Details
Synonyms
Small Ubiquitin-related Modifier 2; HSMT3; SMT3 Homolog 2; Sentrin-2; Ubiquitin-like Protein SMT3A
Product Type
Protein
Properties
Source/Host
E. coli
Sequence
2-8 human SUMO2 (Accession Nr. P0CG47) covalently linked through an isopeptide bond at K11 residue of one SUMO2 molecule and the C-terminal glycine residue of another SUMO2 molecule.
Crossreactivity
Human
Purity
≥95% (SDS-PAGE)
Formulation
Liquid. In 50mM Hepes pH 8.0, 100mM NaCl, 1mM DTT.
Other Product Data
Use:
Formed enzymatically with wild-type human recombinant SUMO-2 linked via lysine 11 which is the point of attachment for the C-terminal glycine of the preceding SUMO-2. Mono-SUMO-2 has been removed from the chain mixture. Ideal for investigating SUMO-binding proteins and as substrates for SUMO-specific proteases. Reaction conditions will need to be optimized for each specific application.
Declaration
Manufactured by Boston Biochem
Shipping and Handling
Shipping
DRY ICE
Short Term Storage
-20°C
Long Term Storage
-80°C
Handling Advice
Aliquot to avoid freeze/thaw cycles.
Use/St
ABI
lity
Stable for at least 1 year after receipt when stored at -80°C.
Documents
MSD
S
No
Product Specification Sheet
Datasheet
Download PDF
Small Ubiquitin-like Modifier 2 (SUMO2), also known as Sentrin2 and SMT3B is synthesized as a 95 amino acid (aa), propeptide with a predicted 11 kDa. SUMO2 contains a two aa C-terminal prosegment and an 18 aa N-terminal protein interacting region between aa 33-50. Human SUMO2 shares 100% aa sequence identity with mouse SUMO2. Di-SUMO2 represents two wild-type recombinant human SUMO2 molecules linked via Lys11, which is the point of attachment for the C-terminal glycine residue of the preceding SUMO2. Di-SUMO2 can be used as a substrate for SUMO-specific isopeptidases (SENPs) and DeSUMOylating Isopeptidase 1 that cleave the isopeptide linkage between two SUMO2 molecules. It can also be used to investigate mechanisms of binding and recognition by SUMO-activating (E1) enzymes, SUMO-conjugating (E2) enzymes, SUMO ligases (E3s) and other proteins that contain SUMO binding domains. SUMOs are a family of small, related proteins that can be enzymatically attached to a target protein by a post-translational modification process termed SUMOylation. Unlike SUMO1 which is usually conjugated to proteins as a monomer, SUMO2 and SUMO3 form high molecular weight polymers on proteins. All SUMO proteins share a conserved ubiquitin domain and a C-terminal diglycine cleavage/attachment site. Following prosegment cleavage, the C-terminal glycine residue of SUMO2 is enzymatically attached to a lysine residue on a target protein.
產(chǎn)品貨號:2789.6